Delivery Order 36F79720D0017-36C24525N0399
Award Date
2/20/25
Potential Completion Date
2/21/25
Potential Value
$40K
Federal Agency
Veterans Integrated Service Network 5
Awardee
Dompe U.s. Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Department of Veterans Affairs (VA) to Dompe U.S. Inc., a foreign-owned, for-profit pharmaceutical manufacturer, against the General Services Administration (GSA) Pharmaceuticals and Drugs schedule (FSS-61-IB). The $19,887.06 firm fixed price order is for the supply of Oxervate, an ophthalmic solution used to treat neurotrophic keratitis. This award is not set-aside and is part of a larger $2.4 million blanket purchase agreement Dompe holds with the VA...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $70,914.40 delivery order to Dompe U.S. Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The firm fixed price order is for the emergency drug OXERVATE and has a completion date of January 3, 2022. Placed against GSA Schedule FSS-61-IB, the award utilizes the schedule's pre-negotiated pricing terms for pharmaceutical products to fulfill an immediate need for...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $18,030.08 delivery order to Dompe U.S. Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB). The delivery order is for OXERVATE PHARMACUETICAL products to support the VA's healthcare programs. Performance will take place in Bartlett, Tennessee, with an expected completion date of February 27, 2022. No set-aside designation was used for this award...
This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 to Dompe U.S. Inc. for the provision of OXERVATE 0.002% ophthalmic solution. With a potential value of $70,344.24 and a completion date of October 10, 2020, this firm fixed price contract calls for Dompe U.S. Inc. to deliver the specified pharmaceutical product to locations within Boston,...
This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 to Dompe U.S. Inc. for the provision of OXERVATE 0.002% ophthalmic solution. With a potential value of $17,728.60 and a completion date of January 5, 2022, this firm fixed price order is for the delivery of the specified pharmaceutical to support care provided by VISN 20, which serves veterans...
This delivery order against the Pharmaceuticals and Drugs schedule, awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12, is for $18,030.08 of OXERVATE 0.002% solution for opthalmic use. The prime contractor is Dompe U.s. Inc. located in San Mateo, California. The order was awarded on February 15, 2022 with a completion date of March 15, 2022. It utilizes firm fixed pricing and has no set-aside designation. The delivery order was...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $70,344.24 delivery order to Dompe U.S. Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The delivery order is for the provision of emergent medication cenegermin-bkbj 0.002% solution, ophthalmic to treat eye diseases or conditions. Performance will occur in Leeds, Massachusetts. The contract has a firm fixed price and is to be completed by August 14,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $72,120.32 delivery order to Dompe U.s. Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), with performance in San Mateo, California. The order is for the specialty drug OXERVATE to support VHA pharmacy programs, with a firm fixed price and completion by March 4, 2022. No set-aside designation was used for this award placed against the GSA...
This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule, awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20, is for $72,120.32 of OXERVATE 0.002% ophthalmic solution. The prime contractor is Dompe U.S. Inc. located in San Mateo, California, where the place of performance will be. The completion date is December 20, 2022. No set-aside designation was used for this contract. The pricing is firm fixed...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...